Blood test may replace risky biopsies for sarcoma patients
NCT ID NCT03896620
First seen Jan 06, 2026 · Last updated May 14, 2026 · Updated 15 times
Summary
This study aims to see if a blood test can detect tumor DNA (ctDNA) in people with soft tissue sarcoma. Currently, doctors need to take a piece of the tumor (biopsy) to diagnose and monitor the disease, which can be risky and difficult. Researchers will collect blood samples from 50 adults with sarcoma and compare the DNA in the blood to the DNA in the tumor. If successful, this could lead to a safer, easier way to diagnose and track sarcoma in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Froedtert Hospital & the Medical College of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.